^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HA-irinotecan

    Associations
    News
    Trials
    Company:
    Upstryve
    Drug class:
    Topoisomerase I inhibitor
    Related drugs:
    Associations
    News
    Trials